Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
In the latest session, Alignment Healthcare Inc (NASDAQ: ALHC) closed at $19.43 up 1.57% from its previous closing price of $19.13. In other words, the price has increased by $1.57 from its previous closing price. On the day, 1.65 million shares were traded. ALHC stock price reached its highest trading level at $19.52 during the session, while it also had its lowest trading level at $18.935.
Ratios:
For a deeper understanding of Alignment Healthcare Inc’s stock, let’s take a closer look at its various ratios. In the meantime, Its Debt-to-Equity ratio is 3.39 whereas as Long-Term Debt/Eq ratio is at 3.38.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Stephens on December 03, 2024, Upgraded its rating to Overweight and sets its target price to $17 from $13 previously.
BofA Securities Upgraded its Neutral to Buy on May 30, 2024, whereas the target price for the stock was revised from $7.75 to $11.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Apr 14 ’25 when JEK TRUST U/A DTD 02/08/2021 bought 270,000 shares for $19.74 per share.
DAWN MARONEY bought 230,000 shares of ALHC for $4,540,200 on Apr 14 ’25. On Apr 01 ’25, another insider, JOYCE CHRISTOPHER J, who serves as the Chief Legal and Admin. Officer of the company, sold 25,000 shares for $18.47 each. As a result, the insider received 461,632 and left with 415,022 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALHC now has a Market Capitalization of 3727295744 and an Enterprise Value of 3588231168. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.38 while its Price-to-Book (P/B) ratio in mrq is 37.32. Its current Enterprise Value per Revenue stands at 1.327 whereas that against EBITDA is -50.246.
Stock Price History:
The Beta on a monthly basis for ALHC is 1.29, which has changed by 2.9252524 over the last 52 weeks, in comparison to a change of 0.07455289 over the same period for the S&P500. Over the past 52 weeks, ALHC has reached a high of $21.06, while it has fallen to a 52-week low of $4.66. The 50-Day Moving Average of the stock is 19.99%, while the 200-Day Moving Average is calculated to be 57.85%.
Shares Statistics:
For the past three months, ALHC has traded an average of 2.60M shares per day and 4018200 over the past ten days. A total of 191.78M shares are outstanding, with a floating share count of 106.41M. Insiders hold about 44.53% of the company’s shares, while institutions hold 56.40% stake in the company. Shares short for ALHC as of 1743379200 were 9501930 with a Short Ratio of 3.65, compared to 1740700800 on 7050837. Therefore, it implies a Short% of Shares Outstanding of 9501930 and a Short% of Float of 7.7299999999999995.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
